The ranibizumab ocular implant (Susvimo) for neovascular age-related macular degeneration (nAMD) will return to the US market shortly after a voluntary hiatus of almost
The United States Food and Drug Administration (FDA) has approved FYB203/Ahzantive (aflibercept-mrbb), a biosimilar to Eylea developed by Formycon.
Optometrists in Sydney and surrounds are invited to attend Eyecare Social, a unique CPD event hosted by WorkRex and Aelo in Surry Hills on
Optometrists interested in expanding their knowledge of orthokeratology are invited to attend an interactive masterclass hosted by the Australian College of Optometry (ACO) in
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
